Mucosa-Associated Microbiota in Gastric Cancer Tissues Compared With Non-cancer Tissues
Overview
Affiliations
The link between microbiota and gastric cancer (GC) has attracted widespread attention. However, the phylogenetic profiles of niche-specific microbiota in the tumor microenvironment is still unclear. Here, mucosa-associated microorganisms from 62 pairs of matched GC tissues and adjacent non-cancerous tissues were characterized by 16S rRNA gene sequencing. Functional profiles of the microbiota were predicted using PICRUSt, and a co-occurrence network was constructed to analyze interactions among gastric microbiota. Results demonstrated that mucosa-associated microbiota from cancerous and non-cancerous tissues established micro-ecological systems that differed in composition, structure, interaction networks, and functions. Microbial richness and diversity were increased in cancerous tissues, with the co-occurrence network exhibiting greater complexity compared with that in non-cancerous tissue. The bacterial taxa enriched in the cancer samples were predominantly represented by oral bacteria (such as , , and ), while lactic acid-producing bacteria (such as and ) were more abundant in adjacent non-tumor tissues. Colonization by , which is a GC risk factor, also impacted the structure of the microbiota. Enhanced bacterial purine metabolism, carbohydrate metabolism and denitrification functions were predicted in the cancer associated microbial communities, which was consistent with the increased energy metabolism and concentration of nitrogen-containing compounds in the tumor microenvironment. Furthermore, the microbial co-occurrence networks in cancerous and non-cancerous tissues of GC patients were described for the first time. And differential taxa and functions between the two groups were identified. Changes in the abundance of certain bacterial taxa, especially oral microbiota, may play a role in the maintenance of the local microenvironment, which is associated with the development or progression of GC.
Emerging roles of intratumoral microbiota: a key to novel cancer therapies.
Fang P, Yang J, Zhang H, Shuai D, Li M, Chen L Front Oncol. 2025; 15:1506577.
PMID: 40071093 PMC: 11893407. DOI: 10.3389/fonc.2025.1506577.
Wizenty J, Sigal M Nat Rev Gastroenterol Hepatol. 2025; .
PMID: 40011753 DOI: 10.1038/s41575-025-01042-2.
Tavano F, Napoli A, Gioffreda D, Palmieri O, Latiano T, Tardio M Microorganisms. 2025; 13(2).
PMID: 40005817 PMC: 11858623. DOI: 10.3390/microorganisms13020452.
Advances in 16S rRNA-Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis.
Wang Y, Qiu X, Chu A, Chen J, Wang L, Sun X Microb Biotechnol. 2025; 18(2):e70115.
PMID: 39992270 PMC: 11849407. DOI: 10.1111/1751-7915.70115.
Davis T, Decker K, Hosseini D, Jameson G, Borazanci E Front Oncol. 2025; 15:1495500.
PMID: 39980568 PMC: 11839409. DOI: 10.3389/fonc.2025.1495500.